CAN AN UNFRACTIONATED HEPARIN-SPECIFIC ANTI-XA ACTIVITY BE USED TO ASSESS THE LEVEL OF RIVAROXABAN IN PATIENTS WITH CANCER-ASSOCIATED THROMBOSIS?
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.